205
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Insights into β-amyloid transition prevention by cucurbit[7]uril from molecular modeling

, &
Pages 9602-9612 | Received 11 Feb 2021, Accepted 14 May 2021, Published online: 27 May 2021
 

Abstract

In this study, comparable molecular dynamic (MD) simulations of 1.2 microseconds were performed to clarify the prevention of the β-amyloid peptide (Aβ1–42) aggregation by cucurbit[7]uril (CB[7]). The accumulation of this peptide in the brain is one of the most harmful in Alzheimer’s disease. The inhibition mechanism of Aβ1–42 aggregation by different molecules is attributed to preventing of Aβ1–42 conformational transition from α-helix to the β-sheet structure. However, our structural analysis shows that the pure water and aqueous solution of the CB[7] denature the native Aβ1–42 α-helix structure forming different compactness and unfolded conformations, not in β-sheet form. On the other hand, in the three CB[7]@Aβ1–42 complexes, it was observed the encapsulation of N-terminal (Asp1), Lys16, and Val36 by CB[7] along the MD trajectory, and not with aromatic residues as suggested by the literature. Only in one CB[7]@Aβ1–42 complex was observed stable Asp23-Lys28 salt bridge with an average distance of 0.36 nm. All CB[7]@Aβ1–42 complexes are very stable with binding free energy lowest than ∼–50 kcal/mol between the CB[7] and Aβ1-42 monomer from MM/PBSA calculation. Therefore, herein we show that the mechanism of the prevention of elongation protofibril by CB[7] is due to the disruption of the Asp23-Lys28 salt bridge and steric effects of CB[7]@Aβ1–42 complex with the fibril lattice, and not due to the transition from α-helix to β-sheet following the dock-lock mechanism.

Communicated by Ramaswamy H. Sarma

Acknowledgements

This research was carried out with the support of the FAPESP (São Paulo Research Foundation) under process number of 2018/19844-8. Arlan S. Gonçalves also acknowledge the PRPPG (grant no 10/2019 – Productivity Researcher Program PPP) to allow available workload for conducting research.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.